text.skipToContent text.skipToNavigation
Need help? Please contact us

You searched for "endothelial/key-applications-for-endothelial-cells.aspx"

981 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • 1(current)
  • 2
  • 3

You searched for "endothelial/key-applications-for-endothelial-cells.aspx"

1,205 Documents found
  • T/G HA-VSMC Transfection Protocol - Nucleofector™ I/II/2b Device Series
    Instructions of use for transfection of T/G HA-VSMC cells with the Cell Line Nucleofector™ Kit V
  • Adopting the rFC Assay for Endotoxin Detection
    Presentation at the 2021 SMi Pharmaceutical Microbiology East Conference that includes topics about the need for an alternative method, regulatory considerations, results from the validation study and applications.
  • Superior Electrophoresis Results with Lonza Reagents and the Azure cSeries Imaging Systems
    This application note demonstrates the high-sensitivity and quality results that can be obtained combining the expertise of Lonza and Azure Biosystems for DNA and protein electrophoresis and analysis.
  • Functional Assay of Neural Activity with Cell-Based Neural Culture Models and Microelectrode Array Technology for Proconvulsant Risk Assessment in the Neutox Pilot Study
    Lonza and Axion Biosystems’ poster from the 2019 SOT meeting discussing the use of primary cortical cell models and microelectrode array (MEA) technology for neurotoxicology and safety pharmacology assessment applications.
  • Analyzing Cell Viability in 3D Tissue Models with the ViaLight™ Plus BioAssay
    Learn how Lonza's ViaLight™ Plus BioAssay can be used to assess cell health in 3D culture
  • Cell culture and cell analysis using the Real Architecture for 3D Tissue (RAFT™) Culture System
    This poster explains how standard analysis techniques, like fluorescence microscopy, can be applied easily to RAFT™ 3D Cell Cultures. In addition, it will be shown how the RAFT™ Technology can be combined with transient transfection approaches using the Lonza 4D Nucleofector™ System.
  • Adherent Nucleofection of Cryopreserved Dissociated Rat Brain Neuronal Cells
    Results for transfecting cultured dissociated rat brain neurons (hippocampal or cortical) using the 4D-Nucleofector Y Unit. It compares results for freshly isolated neurons with Lonza cryopreserved neurons.
  • Bioscience Solutions Catalog 2018
    Catalog-Chapter1-Stem-Cells-2018.pdf
  • The Cell and Gene Therapies Journey from Translation to Commercialization
    Download our comprehensive eBook on how to accelerate cell and gene therapy development, from translation to GMP production and commercialization.
  • Instructions - ToxiLight™ Bioassay Kit Guide
    Instructions for proper use of the ToxiLight™ Bioassay Kit
  • Designing an RNAi Experiment using Nucleofection® – Technical Reference Guide
    The success of an RNAi experiment can be influenced by several parameters. This guide describes the critical steps for setting up an RNAi experiment with siRNA oligos. Partially the guidelines also apply for shRNA.
  • The Automated, Integrated Lab of the Future
    2021 PharmaLab - Robert Luskus
  • QC Testing Lab of the Future White Paper
    News and views from the 2021 Global Endotoxin Testing Summit.
  • The Road to QC Automation
    Securing Investment for a Next-generation Automation Platform
  • 2023 Virtual Endo Summit Article
    2023 Global Endotoxin Testing Summit recap
  • CD34+ Cells for Cell and Gene Therapy Process Development
    In this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade CD34+ cells for cell and gene therapy process development. Please register to read.
  • Instructions for Use
    TheraPEAK™ SfAAV™ Medium
  • Instructions – Sodium Pyruvate Solution
    Information on different Sodium Pyruvate solutions
  • Ensuring Data Integrity in the Bacterial Endotoxins Test
    Lonza_WhitePapers_White_Paper_Ensuring_Data_Integrity_in_the_Bacterial_Endotoxins_Test.pdf
  • Non-viral Gene Modification for Ex-vivo Cell Therapy
    In this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
  • 6
  • 7(current)
  • 8